P-glycoprotein and Mrp1 collectively protect the bone marrow from vincristine-induced toxicity in vivo

por van Tellingen, O, Buckle, T, Jonker, J W, van der Valk, M A, Beijnen, J H
Publicado 2003

Characterisation of tumour vasculature in mouse brain by USPIO contrast-enhanced MRI

por Gambarota, G, Leenders, W, Maass, C, Wesseling, P, van der Kogel, B, van Tellingen, O, Heerschap, A
Publicado 2008

Pharmacokinetic profile and clinical efficacy of a once-daily ondansetron suppository in cyclophosphamide-induced emesis: a double blind comparative study with ondansetron tablets.

por de Wit, R., Beijnen, J. H., van Tellingen, O., Schellens, J. H., de Boer-Dennert, M., Verweij, J.
Publicado 1996

Paclitaxel in self-micro emulsifying formulations: oral bioavailability study in mice

por Oostendorp, Roos L., Buckle, T., Lambert, G., Garrigue, J. S., Beijnen, J. H., Schellens, J. H. M., van Tellingen, O.
Publicado 2010

A validated HPLC-MS/MS method for simultaneously analyzing curcumin, demethoxycurcumin, bisdemethoxycurcumin, tetra-hydrocurcumin and piperine in human plasma, urine or feces

por Kroon, M.A.G.M., van Laarhoven, H.W.M., Swart, E.L., Kemper, E.M., van Tellingen, O.
Publicado 2023

Enhanced oral bioavailability of paclitaxel in mice treated with the P-glycoprotein blocker SDZ PSC 833.

por van Asperen, J., van Tellingen, O., Sparreboom, A., Schinkel, A. H., Borst, P., Nooijen, W. J., Beijnen, J. H.
Publicado 1997